Euthyroid Sick Syndrome in Meningococcal Sepsis: The Impact of Peripheral Thyroid Hormone Metabolism and Binding Proteins
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
CONTEXT AND OBJECTIVES: The objective of this study was to elucidate the influence of disease severity, deiodination, sulfation, thyroid hormone binding, and dopamine use on thyroid function in euthyroid sick syndrome. SETTING: The study was performed at a university-affiliated pediatric intensive care unit (PICU). DESIGN: This was an observational cohort study. PATIENTS: Sixty-nine children with meningococcal sepsis were studied. MAIN OUTCOME MEASURES: Differences in thyroid function among nonsurvivors, shock survivors, and sepsis survivors on PICU admission were the main outcome measures. RESULTS: The main study group consisted of 45 non-dopamine-treated children. All children had decreased total T3 (TT3)/rT3 ratios without elevated TSH. T4 sulfate levels were decreased in 88%. Nonsurvivors had paradoxically higher TT3/rT3 ratios than shock survivors (0.71 vs. 0.30); this ratio also correlated with shorter duration of disease (r = -0.43). TT4 and T4-binding globulin (TBG) levels declined with increasing disease severity. TBG levels correlated inversely with elastase levels (r = -0.46). Only TSH levels were significantly lower in 24 dopamine-treated children compared with non-dopamine-treated children (0.65 vs. 0.84), whereas other thyroid hormones did not significantly differ. Both higher TT3/rT3 ratios and lower TT4 levels were predictive for mortality, but this disappeared when IL-6 was entered into the regression model. CONCLUSIONS: All children with meningococcal sepsis showed signs of euthyroid sick syndrome. Alterations in peripheral thyroid hormone metabolism related inversely to the duration of disease and seemed to be enacted by profound induction of type 3 deiodinase rather than by down-regulation of type 1. Lower TT4 levels were related to increased turnover of TBG by elastase. Dopamine was found to suppress only TSH secretion, not other thyroid hormone levels, on PICU admission. Both the TT3/rT3 ratio and TT4 levels were predictive for mortality, but were not superior to IL-6.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bianco, A. C., Salvatore, D., Gereben, B., Berry, M. J., & Larsen, P. R. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.1.0455 · Cited by 1,853
Peeters, R. P., Wouters, P. J., Kaptein, E., van Toor, H., Visser, T. J., & Van den Berghe, G. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-022013 · Cited by 452 · cited 3×
“Increased levels of biologically inactive rT3 at the expense of decreased TT3 levels are a hallmark of the euthyroid sick syndrome, which are enacted by altered deiodination, the main pathway of peripheral thyroid hormone metabolism (4) (Fig.”
BackgroundSelf-citationThe sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism
Docter, R., Krenning, E. P., de Jong, M., & Hennemann, G. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb02401.x · Cited by 345
The thyroxine-binding proteins
Schussler, G. C. (2000) · Thyroid · doi:10.1089/thy.2000.10.141 · Cited by 329
Tumor Necrosis Factor: A Putative Mediator of the Sick Euthyroid Syndrome in Man*
POLL, T. V. D., ROMIJN, J. A., WIERSINGA, W. M., & SAUERWEIN, H. P. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-6-1567 · Cited by 270
Boelen, A., Kwakkel, J., Thijssen-Timmer, D., Alkemade, A., Fliers, E., & Wiersinga, W. (2004) · Journal of Endocrinology · doi:10.1677/joe.0.1820315 · Cited by 159
LoPresti, J. S., Eigen, A., Kaptein, E., Anderson, K. P., Spencer, C. A., & Nicoloff, J. T. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114343 · Cited by 80 · cited 1×
“Increased levels of cytokines (22–24) and glucocorticoids (3, 25), from either endogenous or exogenous sources, are both indicated as potential mediators in the alterations of thyroid function that occur in critical illness.”
BackgroundSantini, F., Chiovato, L., Bartalena, L., Lapi, P., Palla, R., Panichi, V., Velluzzi, F., Grasso, L., Chopra, I. J., Martino, E., et al. (1996) · European Journal of Endocrinology · doi:10.1530/eje.0.1340045 · Cited by 28
Cited by
Brierley, J., Carcillo, J. A., Choong, K., Cornell, T., DeCaen, A., Deymann, A., Doctor, A., Davis, A., Duff, J., Dugas, M.-A., et al. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819323c6 · Cited by 1,073
Self-citationTSH and thyrotropic agonists: key actors in thyroid homeostasis
Dietrich, J. W., Landgrafe, G., & Fotiadou, E. H. (2012) · Journal of Thyroid Research · doi:10.1155/2012/351864 · Cited by 146
Thyroid axis function and dysfunction in critical illness
Mebis, L., & Van den Berghe, G. (2011) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.03.002 · Cited by 99
Thyroid Hormone Transport into Cellular Tissue
Holtorf, K. (2014) · Journal of Restorative Medicine · doi:10.14200/jrm.2014.3.0104 · Cited by 16
Non-thyroidal Illness Syndrome (Euthyroid Sick Syndrome)
McDermott, M. T. (2019) · Management of Patients with Pseudo-Endocrine Disorders · doi:10.1007/978-3-030-22720-3_26 · Cited by 4
Metadata
- Authors
- den Brinker, M., Joosten, K. F. M., Visser, T. J., Hop, W. C. J., de Rijke, Y. B., Hazelzet, J. A., Boonstra, V. H., & Hokken-Koelega, A. C. S.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-10
- Volume
- 90
- Issue
- 10
- Pages
- 5613-5620
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2089940930
- Cited by
- 95
- References
- 8
- FWCI
- 3.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.